Sai Parenterals Acquires Prathyak Labs for ₹15 Cr

Sai Parenterals Limited has completed the acquisition of a 60% equity stake in Prathyak Laboratories Private Limited, an operating research and development center in Hyderabad, for ₹15 crore. The acquisition was funded from the unutilised net proceeds of the Company's initial public offering. Prathyak Laboratories, now renamed Sai Prathyak Laboratories Private Limited, becomes a direct subsidiary. This acquisition replaces the company's original plan to build a greenfield research center, providing an immediate operational platform with 28 research scientists and a development pipeline of 150 SKUs across 86 molecules. The R&D center specializes in complex and oncology injectables, aligning with Sai Parenterals' strategy to build its regulated-market injectable franchise and support its Australian and New Zealand business. The company also has an option to acquire the remaining 40% stake through a Right of First Refusal.